These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30795972)

  • 1. Is Resolution the End of Inflammation?
    Feehan KT; Gilroy DW
    Trends Mol Med; 2019 Mar; 25(3):198-214. PubMed ID: 30795972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.
    Xiong T; Turner JE
    Semin Immunopathol; 2018 Jul; 40(4):393-406. PubMed ID: 29568972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the resolution of inflammation.
    Gilroy D; De Maeyer R
    Semin Immunol; 2015 May; 27(3):161-8. PubMed ID: 26037968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases.
    Abdolmaleki F; Kovanen PT; Mardani R; Gheibi-Hayat SM; Bo S; Sahebkar A
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):82-91. PubMed ID: 31267470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
    Cardamone C; Parente R; Feo GD; Triggiani M
    Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
    Bellinger DL; Lorton D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neutrophils in inflammation resolution.
    Jones HR; Robb CT; Perretti M; Rossi AG
    Semin Immunol; 2016 Apr; 28(2):137-45. PubMed ID: 27021499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.
    Cai B; Thorp EB; Doran AC; Subramanian M; Sansbury BE; Lin CS; Spite M; Fredman G; Tabas I
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6526-31. PubMed ID: 27199481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of inflammation and mood disorders.
    Chistyakov DV; Astakhova AA; Sergeeva MG
    Exp Mol Pathol; 2018 Oct; 105(2):190-201. PubMed ID: 30098318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis.
    Cadwell K
    Nat Rev Immunol; 2016 Nov; 16(11):661-675. PubMed ID: 27694913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "TRP inflammation" relationship in cardiovascular system.
    Numata T; Takahashi K; Inoue R
    Semin Immunopathol; 2016 May; 38(3):339-56. PubMed ID: 26482920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of innate lymphoid cells in health and disease.
    Mohammadi H; Sharafkandi N; Hemmatzadeh M; Azizi G; Karimi M; Jadidi-Niaragh F; Baradaran B; Babaloo Z
    J Cell Physiol; 2018 Jun; 233(6):4512-4529. PubMed ID: 29058773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.
    O'Donnell JA; Lehman J; Roderick JE; Martinez-Marin D; Zelic M; Doran C; Hermance N; Lyle S; Pasparakis M; Fitzgerald KA; Marshak-Rothstein A; Kelliher MA
    J Immunol; 2018 Jan; 200(2):737-748. PubMed ID: 29212904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of the Resolution of the Inflammatory Response.
    Sugimoto MA; Vago JP; Perretti M; Teixeira MM
    Trends Immunol; 2019 Mar; 40(3):212-227. PubMed ID: 30772190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
    Perucci LO; Sugimoto MA; Gomes KB; Dusse LM; Teixeira MM; Sousa LP
    Expert Opin Ther Targets; 2017 Sep; 21(9):879-896. PubMed ID: 28786708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of chronic inflammatory disease: universal and tissue-specific concepts.
    Schett G; Neurath MF
    Nat Commun; 2018 Aug; 9(1):3261. PubMed ID: 30111884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.